v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (7,131) $ (15,939)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 323 342
Bad debt expense 541 (21)
Inventory reserve 457 1,599
Stock based compensation 476 1,334
Amortization of stock-based marketing services shares issued for services 558 910
Amortization of debt finance costs 1,849 1,801
Other 6 (10)
Effect of changes in assets and liabilities:    
Accounts receivable, net (1,821) 160
Inventories, net (2,812) (937)
Prepaid and other current assets (670) (1,493)
Operating lease right-of-use assets 102 99
Other non-current assets (198) 3
Operating lease obligations (52) (100)
Trade payables 860 1,010
Accrued expenses (1,469) 1,536
Deferred revenue (17) (155)
Net cash used in operating activities (8,998) (9,861)
Investing activities:    
Purchases of property and equipment (359) (302)
Net cash used in investing activities (359) (302)
Financing activities:    
Proceeds from issuance of preference shares and warrants, net 5,148
Proceeds from convertible debt obligations 2,000
Proceeds from trade finance facilities, net 2,845
Repayment of trade finance facilities (2,495) (351)
Proceeds from short-term borrowings, net 1,330 5,792
Repayment of short-term borrowings (4,725) (5,742)
Proceeds from notes payable – related party, net 5,590
Repayment of notes payable – related party (5,090)
Payment of dividends on Series AA Convertible Preferred Stock (506)
Net cash provided by financing activities 3,294 9,692
Effect of exchange rate changes on cash (295) 70
Net change in cash (6,358) (401)
Cash and cash equivalents and restricted cash - beginning of period 7,509 7,910
Cash and cash equivalents and restricted cash - end of period 1,151 7,509
Supplemental disclosures of cash flow information:    
Interest paid on borrowings and bank loans 1,660 154
Reconciliation of cash, cash equivalents, and restricted cash reported in the consolidated balance sheets    
Cash and cash equivalents 1,151 6,159
Restricted cash 1,350
Total cash, cash equivalents and restricted cash presented in the consolidated statements of cash flows 1,151 7,509
Supplemental disclosure of non-cash investing and financing activities:    
Recognition of operating lease right of use assets and lease obligations 1,077
Recognition of debt discounts on short-term borrowings 658 2,886
Fair value of shares issued to extinguish a note payable and accrued interest – related party 508
Financing costs included in accounts payable and accrued expenses 353
Fair value of RSUs issued as a finance cost on notes payable – related party 305
Fair value of shares issued in exchange for services to be received 62 1,488
Cancellation of employee vested options 23
Conversion of convertible debt to common stock 2,000
Related Party [Member]    
Financing activities:    
Proceeds from issuance of common stock and warrants, net 4,050
Proceeds from line of credit – related party $ 5,140